Are ketamine and its enantiomers the answer to treatment-refractory depression?

Jean-Baptiste Belge^{1

2

3

4}, Gabrielle Scantamburlo^{1

2}, Eric Constant⁵

Affiliations

¹ Department of Psychiatry, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
² Psychoneuroendocrinology Unit, University of Liège, Liège, Belgium.
³ Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
⁴ Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of neuropsychiatry, Centre Hospitalier Spécialisé Notre-Dame des Anges, Liège, Belgium.

Editorial

Jean-Baptiste Belge et al. Expert Rev Neurother. 2024 Sep.

. 2024 Sep;24(9):827-830.

doi: 10.1080/14737175.2024.2373302. Epub 2024 Jun 27.

Jean-Baptiste Belge^{1

2

3

4}, Gabrielle Scantamburlo^{1

2}, Eric Constant⁵

¹ Department of Psychiatry, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
² Psychoneuroendocrinology Unit, University of Liège, Liège, Belgium.
³ Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
⁴ Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of neuropsychiatry, Centre Hospitalier Spécialisé Notre-Dame des Anges, Liège, Belgium.

No abstract available

Keywords: Ketamine; depression; enatiomers; esketamine; treatment resistant depression.

Publication types